BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | A076348 | ANI PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Amendment to Suitability Petition from Premier Consulting FDA-2024-P-4954 · 9 docket documents Premier Consulting filed an amendment to an ANDA suitability petition (FDA-2024-P-4954) for Benazepril Hydrochloride and Hydrochlorothiazide Oral Liquid, clarifying in response to FDA feedback that the proposed dosage form is a liquid rather than a solution, suspension, or powder for suspension, wit | Suitability | 2024-12-02 | Granted | Premier Consulting |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.